{"id":"W2898605921","doi":"10.1016/j.jtho.2018.08.608","title":"P1.01-52 BR-34- Randomized Trial of Durvalumab and Tremelimumab +/- Platinum Chemotherapy in Patients with Metastatic Squamous or Non-Squamous NSCLC","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Durvalumab; Tremelimumab; Medicine; Oncology; Pemetrexed; Internal medicine; Clinical endpoint; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Lung cancer; Cancer; Immunotherapy; Pembrolizumab; Progressive disease; Randomized controlled trial; Cisplatin; Ipilimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001056541,0.001511052,0.003208675,0.0002944786,0.0003066007,0.001158377,0.0009287662,0.0009593652,0.008477981],"category_scores_gemma":[0.001069152,0.0007894848,0.002124679,0.0002914662,0.000977403,0.000955732,0.0005558687,0.003836999,0.001358378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001199195,"about_ca_system_score_gemma":0.00103729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001899873,"about_ca_topic_score_gemma":0.005575374,"domain_scores_codex":[0.9994438,0.0002527499,0.00002796191,0.0001204699,0.00003442455,0.0001205383],"domain_scores_gemma":[0.9995953,0.00008095895,0.00008020858,0.00004621118,0.00002359561,0.000173742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9765282,0.001349772,0.000870766,0.0004482332,0.001528958,0.00003469058,0.00002772365,0.0005592771,0.002763656,0.0002060374,0.001170332,0.01451237],"study_design_scores_gemma":[0.9555661,0.03665997,0.003403033,0.00004335401,0.001587609,0.00005262596,0.00002480485,0.0007018368,0.0004477108,0.0002910302,0.001203996,0.00001804829],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863676,0.004136065,0.0004645141,0.001303871,0.0008844401,0.001174368,0.001819844,0.0001491525,0.003700162],"genre_scores_gemma":[0.9895602,0.001437382,0.0006464837,0.0009665977,0.0003590321,0.0006984384,0.001740559,0.0000311629,0.00456006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008477981,"threshold_uncertainty_score":0.02836168,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01844387430919676,"score_gpt":0.3618502880888733,"score_spread":0.3434064137796766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}